淋菌感染症の疫学的・治療学的検討 - Cefetamet pivoxilを用いた検討 -
スポンサーリンク
概要
- 論文の詳細を見る
We studied the epidemiology of 109 cases of gonococcal infections (105 males with urethritis and 4 females with cervicitis), together with the basic and clinical effects of cefetamet pivoxil in the cases. The peak of age distribution of the male patients was in the younger half of their twenties, and all of the 4 female cases were between 20 and 39 years old. The major source of infections in the males younger than 25 years old was their girl friends or so-called pick-up friends, and that of the males older than 25 years old workers serving at an amusement center, for example, bars and so-called special massage parlor, which accounted for about three fourths of the male cases between 35 and 44 years old. The distribution of the MIC (inoculum size; 10(6) CFU/ml) of Cefetamet against beta-lactamase non penicillinase producing Neisseria gonorrhoeae (non-PPNG) ranged from 0.025 to 0.1 microgram/ml and that against beta-lactamase producing Neisseria gonorrhoeae ranged from 0.025 to 0.05 microgram/ml. The isolation rate of PPNG was 10.2% (9/88). In male patients with gonococcal urethritis, the efficacy rate was 100% on days 3 and 7 for 1,000 mg single dose and 7-day treatment and 500 mg single dose treatment. One of the cases treated with 250 mg single dose therapy was unchanged at 3, but the efficacy rate of the remaining cases was 100% at day 7. Complicated urethritis with C. trachomatis was noticed in 25.7% (5/105) of the male urethritis and in 25.0% (1/4) of the female cervicitis cases. The only side effect was diarrhea observed in 1 of the 124 case (0.8%).
論文 | ランダム
- 米国会社・証取法判例研究(193)金融機関の破綻処理とFDICに対する比較過失の抗弁
- 連結経営入門(9・完)連結経営と企業会計--商法会計の証取法会計への接近
- 米国会社・証取法判例研究(191)証券詐欺における支配者責任と誠実の抗弁--Dellastatious v. Williams, 242 F.3d 191(4th Cir, 2001)
- 資料2 改正商法施行規則・改正証取法施行令等関連 営業報告書・招集通知モデルの改正(全国株懇連合会・平成15年4月11日)
- 米国会社・証取法判例研究(190)口頭によるオプションの付与と規則10b-5--Wharf(Holdings) Ltd. v. United Int'l Holdings, Inc., 532 U.S. 588(2001)